Scarica l'app Stockscreener
13.71
0.22%
-0.03
Dopo l'orario di chiusura:
13.75
0.04
+0.29%
Precedente Chiudi:
$13.74
Aprire:
$13.95
Volume 24 ore:
229.95K
Relative Volume:
1.16
Capitalizzazione di mercato:
$537.75M
Reddito:
$49.52M
Utile/perdita netta:
$6.31M
Rapporto P/E:
77.15
EPS:
0.1777
Flusso di cassa netto:
$17.27M
1 W Prestazione:
+11.10%
1M Prestazione:
+19.27%
6M Prestazione:
+73.93%
1 anno Prestazione:
+168.56%
Intervallo 1D:
$13.66
$14.40
Intervallo di 1 settimana:
$11.96
$14.65
Portata 52W:
$3.92
$14.65
Brainsway Ltd Adr Stock (BWAY) Company Profile
Nome
Brainsway Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare BWAY vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
13.71 | 537.75M | 49.52M | 6.31M | 17.27M | 0.1777 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-03-03 | Iniziato | Loop Capital | Buy |
| 2021-07-19 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-20 | Iniziato | Northland Capital | Outperform |
| 2019-05-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-05-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-05-13 | Iniziato | Oppenheimer | Outperform |
| 2019-05-13 | Iniziato | Raymond James | Outperform |
Mostra tutto
Brainsway Ltd Adr Borsa (BWAY) Ultime notizie
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High on Better-Than-Expected Earnings - Defense World
Northland Securities Estimates Brainsway Q1 Earnings - Defense World
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Growth in Short Interest - MarketBeat
Micron To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Brainsway Q1 EPS Estimate Reduced by Northland Securities - MarketBeat
Brainsway (NASDAQ:BWAY) Hits New 1-Year High on Earnings Beat - MarketBeat
Brainsway Q4 Earnings Call Highlights - Yahoo Finance
Northland Securities Comments on Brainsway FY2025 Earnings - MarketBeat
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 41.9% - MarketBeat
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 - ChartMill
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day - ChartMill
Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Brainsway Stock Set to Split on Tuesday, March 3rd (NASDAQ:BWAY) - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 12-Month HighWhat's Next? - MarketBeat
BrainsWay doubles U.S. ADS count in 2-for-1 split on Mar. 3 - Stock Titan
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Significant Decrease in Short Interest - MarketBeat
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Rises By 116.5% - MarketBeat
Phoenix Financial Ltd. Has $949,000 Stake in Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 52-Week HighTime to Buy? - MarketBeat
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Northland Securities Predicts Brainsway Q3 Earnings - MarketBeat
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™ - ChartMill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Down 21.1% in December - MarketBeat
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) - Chartmill
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ - Chartmill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Update - MarketBeat
Investment Analysts’ Weekly Ratings Updates for Brainsway (BWAY) - Defense World
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Eastern Progress
Are Options Traders Betting on a Big Move in BrainsWay Stock? - sharewise.com
BrainsWay Ltd. (NASDAQ:BWAY) Expanding Reach In Mental Health Care - Kalkine Media
FY2025 EPS Estimate for Brainsway Decreased by Analyst - Defense World
Northland Capmk Reduces Earnings Estimates for Brainsway - MarketBeat
Northland Capmk Predicts Weaker Earnings for Brainsway - Defense World
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewswire Inc.
Brainsway (NASDAQ:BWAY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Brainsway (BWAY) Projected to Post Earnings on Tuesday - Defense World
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com
HC Wainwright Has Bearish Forecast for Brainsway Q4 Earnings - MarketBeat
BrainsWay secures two more U.S. mental health provider investments By Investing.com - Investing.com
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - sharewise.com
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy - The Globe and Mail
Brainsway (NASDAQ:BWAY) Shares Up 1.9%Here's What Happened - MarketBeat
Do Options Traders Know Something About Brainsway Stock We Don't? - sharewise.com
Brainsway Ltd Adr Azioni (BWAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):